The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.
Department of Endocrinology, First Hospital of Lanzhou University, Lanzhou 730000, China.
Biomolecules. 2024 Jun 20;14(6):733. doi: 10.3390/biom14060733.
Diabetic kidney disease (DKD) is a common microvascular complication of diabetes and the main cause of end-stage renal disease around the world. Mitochondria are the main organelles responsible for producing energy in cells and are closely involved in maintaining normal organ function. Studies have found that a high-sugar environment can damage glomeruli and tubules and trigger mitochondrial dysfunction. Meanwhile, animal experiments have shown that DKD symptoms are alleviated when mitochondrial damage is targeted, suggesting that mitochondrial dysfunction is inextricably linked to the development of DKD. This article describes the mechanisms of mitochondrial dysfunction and the progression and onset of DKD. The relationship between DKD and mitochondrial dysfunction is discussed. At the same time, the progress of DKD treatment targeting mitochondrial dysfunction is summarized. We hope to provide new insights into the progress and treatment of DKD.
糖尿病肾病(DKD)是糖尿病常见的微血管并发症,也是全球范围内导致终末期肾病的主要原因。线粒体是细胞内产生能量的主要细胞器,与维持正常器官功能密切相关。研究发现,高糖环境可损害肾小球和肾小管,并引发线粒体功能障碍。同时,动物实验表明,靶向线粒体损伤可减轻 DKD 症状,这表明线粒体功能障碍与 DKD 的发生发展密切相关。本文描述了线粒体功能障碍的机制以及 DKD 的进展和发病机制。探讨了 DKD 与线粒体功能障碍的关系。同时,总结了针对线粒体功能障碍治疗 DKD 的进展。我们希望为 DKD 的进展和治疗提供新的思路。